The breakage-fusion-bridge (BFB) cycle as a mechanism for generating genetic heterogeneity in osteosarcoma

被引:37
作者
Selvarajah, Shamini
Yoshimoto, Maisa
Park, Paul C.
Maire, Georges
Paderova, Jana
Bayani, Jane
Lim, Gloria
Al-Romaih, Khaldoun
Squire, Jeremy A.
Zielenska, Maria
机构
[1] Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada
[2] Hosp Sick Children, Dept Pathol & Lab Med, Toronto, ON M5G 1X8, Canada
[3] Univ Toronto, Fac Med, Dept Med Biophys, Toronto, ON M5G 2M9, Canada
[4] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1L5, Canada
[5] Ottawa Gen Hosp, Dept Pathol & Lab Med & Pathobiol, Ottawa, ON K1H 8L6, Canada
基金
加拿大健康研究院;
关键词
D O I
10.1007/s00412-006-0074-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Osteosarcoma (OS) is characterized by chromosomal instability and high copy number gene amplification. The breakage-fusion-bridge (BFB) cycle is a well-established mechanism of genome instability in tumors and in vitro models used to study the origins of complex chromosomal rearrangements and cancer genome amplification. To determine whether the BFB cycle could be increasing the de novo rate of formation of cytogenetic aberrations in OS, the frequency of anaphase bridge configurations and dicentric chromosomes in four OS cell lines was quantified. An increased level of anaphase bridges and dicentrics was observed in all the OS cell lines. There was also a strong association between the frequencies of anaphase bridges, dicentrics, centrosomal anomalies, and multipolar mitotic figures in all the OS cell lines, indicating a possible link in the mechanisms that led to the structural and numerical instabilities observed in OS. In summary, this study has provided strong support for the role of the BFB cycle in generating the extensive structural chromosome aberrations, as well as cell-to-cell cytogenetic variation observed in OS, thus conferring the genetic diversity for OS tumor progression.
引用
收藏
页码:459 / 467
页数:9
相关论文
共 50 条
[1]  
Akerman M, 1996, DIAGN CYTOPATHOL, V15, P17, DOI 10.1002/(SICI)1097-0339(199607)15:1<17::AID-DC5>3.0.CO
[2]  
2-N
[3]   Chromosomal instability in osteosarcoma and its association with centrosome abnormalities [J].
Al-Romaih, K ;
Bayani, J ;
Vorobyova, J ;
Karaskova, J ;
Park, PC ;
Zielenska, M ;
Squire, JA .
CANCER GENETICS AND CYTOGENETICS, 2003, 144 (02) :91-99
[4]   Gene amplifications in osteosarcoma -: CGH microarray analysis [J].
Atiye, J ;
Wolf, M ;
Kaur, S ;
Monni, O ;
Böhling, T ;
Kivioja, A ;
Tas, É ;
Serra, M ;
Tarkkanen, M ;
Knuutila, S .
GENES CHROMOSOMES & CANCER, 2005, 42 (02) :158-163
[5]   Spectral karyotyping identifies recurrent complex rearrangements of chromosomes 8, 17, and 20 in osteosarcomas [J].
Bayani, J ;
Zielenska, M ;
Pandita, A ;
Al-Romaih, K ;
Karaskova, J ;
Harrison, K ;
Bridge, JA ;
Sorensen, P ;
Thorner, P ;
Squire, JA .
GENES CHROMOSOMES & CANCER, 2003, 36 (01) :7-16
[6]  
Bosco G, 1998, GENETICS, V150, P1037
[7]   Genetic instability and darwinian selection in tumours (Reprinted from Trends in Biochemical Science, vol 12, Dec., 1999) [J].
Cahill, DP ;
Kinzler, KW ;
Vogelstein, B ;
Lengauer, C .
TRENDS IN CELL BIOLOGY, 1999, 9 (12) :M57-M60
[8]   Masquerading repeats: Paralogous pitfalls of the human genome [J].
Eichler, EE .
GENOME RESEARCH, 1998, 8 (08) :758-762
[9]  
Ghadimi BM, 2000, GENE CHROMOSOME CANC, V27, P183, DOI 10.1002/(SICI)1098-2264(200002)27:2<183::AID-GCC10>3.3.CO
[10]  
2-G